ERBB2 and neoplasm: Second, the GDF11 H-scores were lower in the patients with a tumor size ≥ 2 cm, pathologic T3 + T4 stages, AJCC III–IV stages, Ki67 ≥ 14% status, HER2-negative, and the luminal B HER2-negative and triple-negative molecular tumor subtypes.